Max Robotics — Global Service Robot Directory + US Certification

About

James Robson has made a pivotal contribution to public health and clinical laboratory science, particularly during the COVID-19 pandemic. His primary research focus lies in the rapid design, buildout, and integration of high-throughput diagnostic laboratories, with an emphasis on automated CLIA (Clinical Laboratory Improvement Amendments)-compliant testing systems. Robson’s most notable achievement is his leadership in establishing a large-scale, automated SARS-CoV-2 testing facility on a major urban campus, a feat documented in his highly cited 2022 paper (19 citations) and its detailed 2021 companion (6 citations). These works provide a comprehensive blueprint for rapidly deploying advanced molecular diagnostics under emergency conditions, detailing the logistical, engineering, and regulatory challenges of scaling up testing capacity from zero to thousands of samples per day. By sharing this operational framework, Robson has enabled other institutions to replicate his model, directly impacting pandemic response efforts. His work exemplifies translational research at its most urgent, bridging laboratory automation, infectious disease control, and healthcare infrastructure. For students and researchers in clinical microbiology or health systems engineering, Robson’s case study offers a masterclass in crisis-driven innovation and the power of interdisciplinary collaboration.